for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zoono Group Ltd

ZNO.AX

Latest Trade

3.12AUD

Change

-0.02(-0.64%)

Volume

777,531

Today's Range

3.05

 - 

3.18

52 Week Range

0.06

 - 

3.29

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Pricing

Previous Close
3.14
Open
3.17
Volume
777,531
3M AVG Volume
30.81
Today's High
3.18
Today's Low
3.05
52 Week High
3.29
52 Week Low
0.06
Shares Out (MIL)
163.31
Market Cap (MIL)
513.74
Forward P/E
--
Dividend (Yield %)
--

Next Event

Zoono Group Ltd Annual Shareholders Meeting

Latest Developments

更多

Zoono Says Invoiced B2b Sales In Excess Of NZ$11 Mln For April

Johns Lyng Group Signs Agreement With Zoono

Zoono Group Enters Agreement With Restorx Australia

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Zoono Group Ltd

Zoono Group Limited, formerly Goldsearch Limited, is an Australia-based company, engaged in the development, manufacture and global distribution of antimicrobial solutions. The Company has developed Zoono Molecule. Zoono Molecule is an antimicrobial that bonds to any surface, including hard surfaces, textiles, fabrics, and skin. Zoono Molecule kills pathogens, including bacteria, viruses, algae, fungi and mould. Its products include Hand Sanitiser GermFree24, Zoono SkinClear, Zoono Foot Guard, Odor Guard, Bathroom Microbe Shield, Kitchen Microbe Shield, Sport Microbe Shield, All Purpose Microbe Shield, Wet Wipes, Zoono Z-71 Surface Sanitiser, ZoonoTex Z-35 Textile Treatment, Zoono Deodorant, Zoono Mould Guard, Zoono Ultra, Zoono Aerosol, Zoono Room Sanitiser and Deodoriser, and Zoono Femme Hygiene. The Company’s products are applied in areas, including hospitals, medical facilities, laboratories, veterinary, homes, poultry and food processing.

Industry

Personal & Household Prods.

Contact Info

L 12 225 George St

SYDNEY, NSW

2000

Australia

+61.2.80428481

http://www.goldsearch.com/

Executive Leadership

Paul Ravlich

Chief Financial Officer

Paul Hyslop

Managing Director

Elissa Hansen

Interim Director

Don Clarke

Non-Executive Independent Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
195.60
Price To Book (MRQ)
170.30
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
18.12
LT Debt To Equity (MRQ)
5.05
Return on Investment (TTM)
-42.54
Return on Equity (TTM)
-34.53

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up